课题基金 / 基金详情

Effects of Intravenous anesthetics on Phosphatidylinositol Response of Spinal Descending Inhibitory Pathways of Rat

Effects of Intravenous anesthetics on Phosphatidylinositol Response of Spinal Descending Inhibitory Pathways of Rat
静脉麻醉药对大鼠脊髓下降抑制通路磷脂酰肌醇反应的影响
批准号:
10671421
负责人:
SHIBATA Osamu
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

SHIBATA Osamu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Noradrenergic neurons arise from the locus coeruleus and project widely to the spinal cord, cerebral cortex andothers. Noradrenergic pathways in the spinal cord are considered to be one of the central descending inhibitory influences on spinal sensory transmission. Norepinephrine (NE) in the central nervous system has the effect to stimulate phosphatidylinositol (PI) response through aradrenergic receptors. The present study was designed to examine the effects of intravenous anesthetics on NE-induced PI response of rat spinal cords. Materials and Methods: Male Wistar ratsweighing 250-350 g were used for the experiments. , The rats were anesthetized with pentobarbital and their thoracic spinal cord was rapidly isolated. The spinal cord waschopped into 1-mm-wide slices. Three pieces of the slice were placed in small flat-bottomed tubes andincubated in K-H solution containing 5 mM LiCI. The effects of intravenous anesthetics on NE-induced inositol monophosphate (IP_1) accumulation were examined. We measured [^3H]IP_1 in spinal cord slices incubated with [^3H]myo-inositol with aliquid scintillation counter. Results : NE-induced IP_1 accumulation of spinal cord slices was attenuated dose-dependently by droperidol, but was not attenuated by ketamine, fentanyl and midazolam.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Iwanaga S, Shibata O, Tsuda A, Hashimoto S, Makita T, Cho S, Sumikawa K: "The role of alpha1 - adrenocedptors in the clonidine-induced contraction and relaxation of rat aorta"Res Commun Mol Pathol Pharmacol. 102(2). 137-47 (1998)
Iwanaga S、Shibata O、Tsuda A、Hashimoto S、Makita T、Cho S、Sumikawa K:“α1-肾上腺素受体在可乐定诱导的大鼠主动脉收缩和舒张中的作用”Res Commun Mol Pathol Pharmacol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shibata O, Saito M, Hashimoto S, Sakai K, Makita T, Sumikawa K: "Clonidine attenuates the carbachol-induced contractile and phosphatidylinositol responses of rat trachea"J. Pharm Parmacol. 52(12). 1523-8 (2000)
Shibata O、Saito M、Hashimoto S、Sakai K、Makita T、Sumikawa K:“可乐定减弱卡巴胆碱诱导的大鼠气管收缩和磷脂酰肌醇反应”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shu Iwanaga: "The role of α_1-adrenoceptors in clonidine-induced contraction and relaxation of cut aorta" Research communications in molecular pathology and pharmacology. (in press).
Shu Iwanaga:“α_1-肾上腺素受体在可乐定诱导的主动脉收缩和舒张中的作用”分子病理学和药理学研究通讯(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shibata O, Saitgo M, Maekawa T, Shibata S, Makita T, Sumikawa K: "There is no direct relationship between PI response and smooth muscle contraction of rat trachea stimulated by alpha-agonists"Can J anaesth. 43(8). 830-1 (2001)
Shibata O、Saitgo M、Maekawa T、Shibata S、Makita T、Sumikawa K:“PI 反应与 α 激动剂刺激的大鼠气管平滑肌收缩之间没有直接关系”Can J anaesth。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Development of Innovative Targeting Hybrid Artificial Pulmonary Surfactant Preparations by Nanomedicine
    • 批准号:
      26350534
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2014
    • 负责人:
      SHIBATA Osamu
    • 依托单位:
    Development of Innovative Targeting Artificial pulmonary surfactant preparations by Nanomedicine
    • 批准号:
      23510134
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2011
    • 负责人:
      SHIBATA Osamu
    • 依托单位:
    Mechanisms of contraction/relaxation of airway smooth muscle : relationship between β-antagonist and Rho-kinase pathway
    • 批准号:
      19591804
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2007
    • 负责人:
      SHIBATA Osamu
    • 依托单位:
    Basic research and development of de novo-designed peptide/fluorinated carbon hybrid artificial lung surfactant
    海外基金